[1]
“Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations”, Swiss Med Wkly, vol. 140, no. 1516, pp. 1–21, Apr. 2010, doi: 10.4414/smw.2010.12989.